Ahmad Nader Fasseeh
Overview
Explore the profile of Ahmad Nader Fasseeh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
19
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fasseeh A, Korra N, Aljedai A, Seyam A, Almudaiheem H, Al-Abdulkarim H, et al.
Int J Equity Health
. 2025 Feb;
24(1):56.
PMID: 40011905
Background: Rare diseases, defined variably by global regions, collectively impact approximately 300 million individuals despite affecting small population segments individually. Historically there were no treatments developed for these conditions, leading...
2.
Aldallal S, Farghaly M, Fahmy S, Alnaqbi K, Al Naeem W, Alsaadi M, et al.
BMJ Open
. 2024 Nov;
14(11):e090344.
PMID: 39496369
Background: In the evolving healthcare landscape of the United Arab Emirates (UAE), establishing cost-effectiveness thresholds (CETs) is pivotal to informing decision-makers about the value of health technologies. Objective: This study...
3.
Al Rashdi I, Al Balushi S, Al Shuaili A, Al Rashdi S, Ibrahim Al Bulushi N, Ibrahim Al Kindi A, et al.
J Health Organ Manag
. 2024 Sep;
38(9):241-257.
PMID: 39308088
Purpose: Health technologies are advancing rapidly and becoming more expensive, posing a challenge for financing healthcare systems. Health technology assessment (HTA) improves the efficiency of resource allocation by facilitating evidence-informed...
4.
Alnaqbi K, Elshamy A, Gebran N, Fahmy S, Aldallal S, Korra N, et al.
Value Health Reg Issues
. 2024 Jun;
43:101012.
PMID: 38861786
Objectives: Healthcare research and development have accelerated at an unprecedented rate creating a challenge even for high-income countries to finance all new technologies. Health technology assessment (HTA) aims to maximize...
5.
Elezbawy B, Farghaly M, Al Lafi A, Gamal M, Metni M, Visser W, et al.
Value Health Reg Issues
. 2024 May;
42:100987.
PMID: 38703753
Objectives: Atopic dermatitis (AD) creates a significant burden on patients and society. This study proposes a set of health policy interventions that can reduce the burden of AD in the...
6.
Fasseeh A, Elezbawy B, El-Fass K, GamaI M, Seyam A, Hayek N, et al.
J Pharm Policy Pract
. 2023 Jun;
16(1):79.
PMID: 37365620
Background: Biosimilars constitute a pathway for sustainable financing of healthcare systems in the era of expensive biologics. However, such a pathway is not free of challenges. Since the biosimilars market...
7.
Fasseeh A, Elezbawy B, Gamal M, Seyam A, Abourawash A, George M, et al.
Front Public Health
. 2022 Dec;
10:896175.
PMID: 36582366
Background: The Egyptian healthcare system is currently in the early phase of health technology assessment (HTA) implementation. The aim of this study is to propose an implementation roadmap based on...
8.
Elezbawy B, Fasseeh A, Fouly E, Tannira M, Dalle H, Aderian S, et al.
Dermatol Ther (Heidelb)
. 2022 Nov;
13(1):131-146.
PMID: 36445612
Introduction: Atopic dermatitis (AD) is a chronic skin disease that poses a significant burden on both patients and the society. AD causes the highest loss in disability-adjusted life years compared...
9.
The humanistic and economic burden of atopic dermatitis among adults and adolescents in Saudi Arabia
Elezbawy B, Fasseeh A, Fouly E, Abu Esba L, Al Abdulkarim H, Al-Haddab M, et al.
J Med Econ
. 2022 Nov;
25(1):1231-1239.
PMID: 36426726
Atopic dermatitis (AD) is a chronic skin disease that creates a significant burden to patients and society. There is scarcity in local data about the burden of AD in the...
10.
Elezbawy B, Fasseeh A, Nemeth B, Gamal M, Eldebeiky M, Refaat R, et al.
BMC Med Inform Decis Mak
. 2022 Nov;
22(1):289.
PMID: 36352382
Background: With the availability of several similar medical devices performing the same function, choosing one for reimbursement is not easy, especially if purchased for a large number of patients. The...